Divis Laboratories share price: Ashis Biswas of CapitalVia puts Target Price at Rs 3770; Sharekhan says THIS about the pharma stock
Ashis Biswas, Head of Technical Research at CapitalVia Global Research highlights Fundamentals and Technical Analysis on Divi’s Laboratories. The target price on Divi’s Lab is Rs 3770. In addition to having a solid base in the industry, Divi's Laboratories is extending its product offerings in the generic API segment, developing 16 additional APIs to lead the next phase of growth and the subsequent DMF filing
Sharekhan says that Divis Laboratories is expected to benefit from strong growth likely in the global active pharmaceutical ingredients (API) space: Reuters